In a groundbreaking milestone for regenerative medicine and cell therapy, the Abu Dhabi Stem Cells Center (ADSCC) has successfully developed clinical-grade induced pluripotent stem cells (iPSCs). These iPSCs, crafted through ADSCC’s proprietary virus-free protocols, meet stringent Good Manufacturing Practice (GMP)…
:In a significant leap for patient care innovation, Hamad Medical Corporation (HMC) has introduced Qatar’s—and the region’s—first Neurocardiac Rehabilitation Program. This pioneering initiative addresses the complex needs of patients suffering from both cardiac and neurological conditions, setting a new standard…
In a groundbreaking move, Abu Dhabi’s Department of Health Abu Dhabi has granted early access to WINREVAIR, a cutting-edge medication for Pulmonary Arterial Hypertension (PAH). This initiative marks a pivotal moment, as Abu Dhabi becomes the first in the region…
The Department of Health – Abu Dhabi (DoH), in partnership with the Authority of Social Contribution – Ma’an, has allocated over AED 19 million in grants through the Healthcare Research and Innovation Fund. These grants aim to propel advancements in…
BioSapien, a pioneering drug delivery platform focused on localized cancer treatment, has announced the successful closure of a $5.5 million (AED 20.2 million) pre-Series A funding round. The round was led by Global Ventures, with participation from Dara Holdings. Fueling…
